Invention Application
- Patent Title: INHIBITORS OF HEPATITIS C VIRUS REPLICATION
- Patent Title (中): HEPATITIS C VIRUS REPLICATION的抑制剂
-
Application No.: US14473117Application Date: 2014-08-29
-
Publication No.: US20140371138A1Publication Date: 2014-12-18
- Inventor: Craig A. Coburn , John A. McCauley , Steven W. Ludmerer , Kun Liu , Joseph P. Vacca , Hao Wu , Bin Hu , Richard Soll , Fei Sun , Xinghai Wang , Man Yan , Chengren Zhang , Mingwei Zheng , Bin Zhong , Jian Zhu
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Main IPC: C07K5/08
- IPC: C07K5/08 ; A61K38/05 ; A61K38/06 ; C07D471/04 ; A61K31/437 ; C07K5/06 ; A61K45/06
Abstract:
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
Public/Granted literature
- US09090661B2 Inhibitors of hepatitis C virus replication Public/Granted day:2015-07-28
Information query
